State Medicaid programs must cover medication assisted treatment under a new mandatory benefit that takes effect today.

The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018 added the benefit to increase access to evidenced-based treatment for opioid use disorder for Medicaid beneficiaries.

Specifically, states must cover all forms of drugs and biologicals that the Food and Drug Administration has approved or licensed for MAT to treat OUD, the Centers for Medicare & Medicaid Services said today in a reminder notice

 

Related News Articles

Perspective
As we’ve seen from recent media reports, Congress — and especially the House right now — continues to struggle to put together a plan to keep the government…
Headline
As millions of people are losing their Medicaid coverage as a result of the redetermination process, hospitals and health systems are seeing substantial…
Blog
More than 90 million people had access to health care through Medicaid’s pandemic-related continuous coverage provisions. That coverage ended March 31, 2023,…
Headline
The Centers for Medicare & Medicaid Services Sept. 18 finalized select provisions in its proposed rule to streamline Medicaid and Children’s Health…
Headline
AHA today voiced support for a provision in the Lower Costs, More Transparency Act (H.R. 5378) that would suspend for two years the Medicaid disproportionate…
Headline
The Health and Human Services Office of Inspector General Aug. 28 released a strategic plan to align its audits, evaluations, investigations and…